Yatharth Hospital & Trauma Care Services Limited (YATHARTH.NS)
- Previous Close
510.75 - Open
510.90 - Bid 508.50 x --
- Ask 508.85 x --
- Day's Range
504.40 - 514.75 - 52 Week Range
345.60 - 693.00 - Volume
104,597 - Avg. Volume
393,391 - Market Cap (intraday)
49.04B - Beta (5Y Monthly) --
- PE Ratio (TTM)
34.60 - EPS (TTM)
14.71 - Earnings Date May 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
598.00
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in Delhi and Madhya Pradesh. The company offers services in the areas of medicine; cardiology; neurosciences; general surgery; nephrology and urology; pediatric; gastroenterology; pulmonology; gynecology; orthopedics and spine and rheumatology; plastic and cosmetic surgery; ear, nose, and throat; endocrinology; critical care; dermatology; nuclear medicine; cancer and bone marrow transplant; GI surgery and liver transplant; robotic surgery; IVF and fertility; ophthalmology; dentistry; psychology and psychiatry; physiotherapy and rehabilitation; anesthesiology; radiology; pathology and laboratory medicine; nutrition and health; and interventional spine and pain medicine. It also sells medicines and canteen food, etc. Yatharth Hospital & Trauma Care Services Limited was incorporated in 2008 and is based in Noida, India.
www.yatharthhospitals.comRecent News: YATHARTH.NS
View MorePerformance Overview: YATHARTH.NS
Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: YATHARTH.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: YATHARTH.NS
View MoreValuation Measures
Market Cap
49.18B
Enterprise Value
44.15B
Trailing P/E
34.70
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.14
Price/Book (mrq)
3.07
Enterprise Value/Revenue
5.01
Enterprise Value/EBITDA
18.67
Financial Highlights
Profitability and Income Statement
Profit Margin
14.83%
Return on Assets (ttm)
7.41%
Return on Equity (ttm)
10.40%
Revenue (ttm)
8.8B
Net Income Avi to Common (ttm)
1.31B
Diluted EPS (ttm)
14.71
Balance Sheet and Cash Flow
Total Cash (mrq)
5.15B
Total Debt/Equity (mrq)
0.71%
Levered Free Cash Flow (ttm)
-1.55B